Pharma company ACDIMA is shopping for a new acquisition target, CEO Olfat Ghorab tells Al Borsa. The company’s board of directors has also signed off on new planned investments that will see ACDIMA either add new production lines to its existing capacity or invest in a promising pharma manufacturer, she adds. The state-owned ACDIMA had reportedly acquired United Pharma IV last August in a transaction valued at over EGP 320 mn.
More from Enterprise
How correspondent banking works, and what the FinCEN clampdown on Banque Misr UAE means for business
As FinCEN proposes cutting Banque Misr’s UAE branches from USD…
Inside the financing of Egypt’s IPP boom
The contracts and the resources are proven, so the open…
EGX30 gained 2.79% in 3Q, but September gave back most of its July-August run, with mid-caps falling the hardest
Small- and mid-cap indices widened their lead over the benchmark…
Egyptian-UK fintech Zeal raises USD 10 mn to back expansion plans
The London-based, Egyptian-founded fintech is preparing to activate its loyalty…